7 results
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
PCI in Acute MI ... with Cardiogenic ... #EBM #Cardiology ... #VisualAbstract ... #NEJM
An AAV5 vector with a functional factor VIII gene tested in men with hemophilia A #EBM
hemophilia A #EBM ... #Honc #hemophilia ... GeneReplacementTherapy #VisualAbstract ... #NEJM
CULPRIT-SHOCK Visual Abstract Infographic

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

https://www.nejm.org/doi/full/10.1056/NEJMoa1710261

CONCLUSIONS:  Among
Infographic PCI ... Infarction and Cardiogenic ... infarction with cardiogenic ... #Multivessel #EBM ... #VisualAbstract
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... ALKPositive #NSCLC #VisualAbstract ... #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
PCI Strategies in ... Infarction and Cardiogenic ... #EBM #Cardiology ... CulpritOnly #shock #cardiogenic ... #NEJM
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction (VALIDATE-SWEDEHEART) #EBM #Cardiology #VALIDATE #SWEDEHEART #Bivalirudin #Heparin #PCI #VisualAbstract
VALIDATE-SWEDEHEART) #EBM ... Bivalirudin #Heparin #PCI ... #VisualAbstract ... #NEJM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #CULPRITSHOCK #PCI ... CulpritOnly #shock #cardiogenic ... #NEJM